| Name | Title | Contact Details |
|---|
Esquire, a national provider of court reporting services and technology, helps law firms, insurance companies and corporate legal departments get depositions right every time. No matter where your deposition occurs, you want a worry-free, personal experience that yields quick, accurate transcripts, more value for your money, and the chance to do your best work. With a fresh eye on the future and technology to make your life easier, we do depositions differently.
LUCKETT ASSOCIATES is a Louisville, KY-based company in the Business Services sector.
For over 30 years, Heritage Oaks Bank has been the financial services employer of choice on California’s Central Coast. As a community bank with over $1.7 billion in assets headquartered on the Central Coast, we offer local decision-making and career advancement opportunities for talented, driven self-starters. Heritage Oaks Bank has locations serving the communities of Paso Robles, Templeton, Cambria, Morro Bay, Atascadero, San Luis Obispo, Arroyo Grande, Santa Maria, Goleta, Santa Barbara, and Oxnard. We are looking for extraordinary, engaging, and committed team players.
Capitol Crating is a Sacramento, CA-based company in the Business Services sector.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.